A Trial of an Adolescent Male Sexual Health Intervention
DrEric
A Digital Intervention to Improve the Sexual and Reproductive Health of Male Adolescent Emergency Department Patients
2 other identifiers
interventional
119
1 country
1
Brief Summary
Early unintended fatherhood and rates of sexually transmitted infections remain national concerns, disproportionately affecting minority, underserved adolescent males, many of whom frequently use emergency departments (EDs) for medical care. EDs must implement effective sexual and reproductive health interventions that are evidence-based and reproducible. This research will conduct pilot testing of a personalized and interactive digital intervention specifically targeting adolescent males entitled Dr. Eric that is theory-based, user-informed, and scalable across EDs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2021
CompletedStudy Start
First participant enrolled
July 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2022
CompletedResults Posted
Study results publicly available
June 6, 2024
CompletedJuly 9, 2024
June 1, 2024
1.3 years
June 30, 2021
April 4, 2024
June 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Number of Eligible Participants Who Agreed to be Enrolled in the Study
Implementation, feasibility: This outcome is designed to measure feasibility - the extent to which an innovation can be used in a setting. The investigators will measure the number of participants who are eligible, and agree to be enrolled into the study.
From day 1 of enrollment until the final day of enrollment (1 year)
Number of Participants That Are Lost to Follow up (at Each Time Point)
Implementation, feasibility: This outcome is to measure feasibility for both arms in which feasibility is defined as the extent to which an innovation can be used in a setting. The investigators will measure the number of participants in each arm that are lost to follow up in each respective arm at the 6 and 13 week time point. Lost to follow up means that we tried to contact the participant to assess outcome measures but they did not respond to texts or phone calls.
6 and 13 weeks
Total Number of Participants Who Demonstrated Acceptability (Intervention Arm ONLY)
Implementation, acceptability: This outcome is to measure acceptability for the intervention group only. Acceptability is the extent to which the innovation is agreeable to a stakeholder. The investigators asked the Agree/Disagree question of "Dr. Eric meets my approval," as self-reported after app completion.
From day 1 of enrollment until the final day of enrollment (1 year)
The Number of Participants Who Interacted With All 5 Educational Modules (Intervention Arm ONLY)
Implementation, adoption: This outcome is for the intervention group only. Th investigators assessed adoption by measuring the number of intervention participants who interacted with all 5 educational modules, based off of data that is recorded by the app.
From day 1 of enrollment until the final day of enrollment (1 year)
Number of Participants Who Opt Out of the Texting Messaging Component of the Program (Intervention Arm ONLY)
Implementation, fidelity: This outcome is for the intervention group only. Fidelity is the extent to which an intervention is used as intended. This outcome measures the number of participants in the intervention group who opt out of the texting messaging component of the program.
3 months
Percentage of Condom Use Among Participants
Efficacy, Consistent Condom Use: This outcome is designed to measure efficacy and is a self-reported outcome and only includes participants who completed follow-up at 13 weeks. Percentages are calculated by dividing the total number of episodes of vaginal intercourse by the total number of times a male condom was used during vaginal intercourse over the past 4 weeks to report percentage of condom use within each arm.
3 months (or 13 weeks)
Percentage of Condom Use Among Participants
Efficacy, Consistent Condom Use: This outcome is designed to measure efficacy and is a self-reported outcome. This outcome only includes participants who completed follow-up at 6 weeks and were sexually active in the prior 4 weeks. The percentages are calculated by dividing the total number of episodes of vaginal intercourse by the total number of times a male condom was used during vaginal intercourse over the past 4 weeks to report percentages of condom use within each arm.
6 weeks
Secondary Outcomes (7)
Number of Participants Who Had Intercourse Over the Past 4 Weeks
3 month (13 weeks)
Number of Participants Who Talked to a Partner About Ways to Prevent Pregnancy Over the Past 3 Months
3 month (13 weeks)
Number of Participants Who Tested for a Sexually Transmitted Infection Over the Past 3 Months
3 month (13 weeks)
Number of Participants Who Tested for HIV Over the Past 3 Months
3 month (13 weeks)
Number of Participants Who Consistently Used Condoms at Every Intercourse
3 months (or 13 weeks)
- +2 more secondary outcomes
Study Arms (2)
Dr. Eric Digital Health Intervention
EXPERIMENTALParticipants will interact with an ED-based iPad and the Dr. Eric app for a recorded period of time. After completion, an animated video will explain the ERIC texting program and "live" office hours. The participant enters his phone number and then receives a welcome text. Weekly texts are sent directly to the participant phone via short message service (SMS).
Standard of Care
NO INTERVENTIONParticipants randomized to the SC arm will receive standard medical care as determined by the ED provider, which is typically referral to a primary care or adolescent provider. Mobile telephone numbers will be collected for follow up purposes.
Interventions
Dr. Eric is a user-informed, theory-based, digital health intervention that aims to improve adolescent male SRH. This ED-based intervention consists of two parts-an interactive, tailored app and 3 months of personalized, two-way text messaging. It is based on an evidence-based sexual health curriculum we developed using established behavioral theories, prior literature, input from key stakeholders, qualitative patient interviews, and our prior ED-based work.
Eligibility Criteria
You may qualify if:
- ED male adolescent patients aged 14-21 years
- sexually active (vaginal intercourse) with females in the past 3 months
You may not qualify if:
- do not own a mobile phone
- too ill per the attending
- are cognitively impaired
- does not speak English
- want their partner to become pregnant in the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
Columbia University Medical Center
New York, New York, 10528, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study included individuals who predominately identified as Hispanic and "more than one race"; the investigators did not ask for more granular race and ethnicity data. Also, the investigators were limited in their ability to assess additional measures of adoption and fidelity such as time spent on the app, which would have represented real use. For the primary outcome, the investigators measured condom use as a group; different results could occur if they measured use by person.
Results Point of Contact
- Title
- Lauren Chernick, MD, MSc
- Organization
- Columbia University
Study Officials
- PRINCIPAL INVESTIGATOR
Lauren Chernick, MD MSc
Columbia University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessments will be electronic. If assessed via phone call, outcome assessors will be blinded to study arm.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Emergency Medicine
Study Record Dates
First Submitted
June 30, 2021
First Posted
July 20, 2021
Study Start
July 26, 2021
Primary Completion
November 20, 2022
Study Completion
November 20, 2022
Last Updated
July 9, 2024
Results First Posted
June 6, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will become available after study analysis is completed, at least one year after study completion.
- Access Criteria
- Even though the final dataset will be stripped of identifiers prior to release for sharing, we believe that there remains the possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.
The final dataset will include self-reported demographic and behavioral data from baseline questionnaires, telephone follow up, and text message data collection. It will also contain usability testing information. All participants will be assigned a unique identifier and all data will remain confidential.